Diagnosis of Benign Prostatic Hyperlasia (BPH)

Header Cap

It is typical for physicians to first gather a detailed medical history to determine the severity of the symptoms and diagnose benign prostatic hyperplasia. A physical examination, such as a digital rectal exam (DRE) which enables physicians to asses the size and shape of the prostate, is essential for proper diagnosis. A DRE procedure involves a doctor inserting a finger into the rectum and feeling the prostate gland to detect an enlarged prostate. This procedure also helps to detect prostate cancer.

Other tests include:

Urine Analysis – can detect infections, prostatitis, cystitis, urinary tract infection and other conditions

Prostatic Specific Antigen (PSA) test – a blood test that examines the level of PSA in the bloodstream

Uroflow – measures the strength and the amount of urine flow over time

Ultrasound – the use of sound waves to estimate the size of the prostate, detect tumor and other problems such as kidney obstruction and kidney stones

Cystoscopy – a small tube with lens is inserted through the opening of the urethra through the penis under local anesthesia

BP-Q COMPLEX

60 1000 mg tablets (30-day supply)

BP Q is a new all natural formula for addressing the symptoms associated with benign prostatic hyperplasia (BPH).

$39.99

 

 

 

The statements contained in this site have not been evaluated by the FDA. The products detailed on this site are not meant to diagnose, treat, cure or prevent any disease. If a medical condition exists, see your health care professional.

© Farr Laboratories 2008 -- ph: 877-284-3976

Evidence-based nutraceutical for maintaining prostate, bladder and colon health